Skip to main content

Day: February 12, 2020

H2O Innovation exécute son plan d’affaires : présente une amélioration financière soutenue et complète une acquisition stratégique

Faits saillantsRéalisation de l’acquisition de Genesys Holdings Limited et de ses filiales, Genesys Manufacturing Limited, Genesys International Limited et de Genesys North America, LLC (collectivement, « Genesys »), un groupe de sociétés fermées établies au Royaume-Uni;Croissance soutenue des revenus de 13,5 %, par rapport à la même période de l’exercice financier précédent, pour atteindre 33,3 M $ pour le deuxième trimestre de l’exercice financier 2020;Marge bénéficiaire brute avant amortissement représentant 24,8 % des revenus de la Société pour le deuxième trimestre de l’exercice financier 2020, comparativement à 21,3 % pour le deuxième trimestre de l’exercice financier précédent;BAIIA ajusté1 de 2,3 M $, ou 6,9 % des revenus, pour le deuxième trimestre de l’exercice financier 2020, comparativement à 1,4 M $ ou 4,7 % des revenus,...

Continue reading

GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Fourth Quarter and Year Ending December 31, 2019 and Host Conference Call on February 25th, 2020

LONDON and CARLSBAD, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, will announce on February 25th, 2020 its financial results for the fourth quarter and year ending December 31st, 2019. GW will also host a conference call the same day at 4:30 p.m. ET. Conference call information will be provided in the financial results press release. A replay of the call will also be available through the Company’s website (www.gwpharm.com) shortly after the call.About GW Pharmaceuticals plc and Greenwich Biosciences, Inc.Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel...

Continue reading

Aeterna Zentaris to Present at Noble Capital Markets’ 16th Annual Investor Conference

CHARLESTON, S.C., Feb. 12, 2020 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that Dr. Klaus Paulini, Chief Executive Officer of Aeterna, will present at NobleCon16 – Noble Capital Markets’ 16th Annual Investor Conference on Monday, February 17th at 11:30 a.m. ET in Hollywood, Florida.As part of his presentation, Dr. Paulini will provide a corporate overview and update on the Company’s lead product, Macrilen™ (macimorelin), the only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). Dr. Paulini’s slide presentation will be made available on the Company’s website on Monday, February 17th.In...

Continue reading

Hammer Fiber Optics Holdings Corp Announces Endstream’s Caribbean Direct Wholesale Voice Service

PISCATAWAY, N.J., Feb. 12, 2020 (GLOBE NEWSWIRE) — Hammer Fiber Optics Holdings Corp (OTCQB: HMMR) announced today that its subsidiary, Endstream Communications has launched its Caribbean Direct wholesale voice service. The first two markets launched are Dominica and St. Vincent. Endstream recently completed its initial testing with multiple clients.“Hammer will now begin to derive new revenues from those markets. Implementing the over-the-top networks which is the first phase of our deployment in each country. We will see the benefits in coming quarters,” said Erik Levitt, Hammer’s CEO.“Building on our Over-the-Top platform is a priority,” said Kristen Vasicek, Hammer’s COO. “Those services are integral to our goal of providing a complete wireless retail solution using either fixed wireless or mobility.”The first phase of the deployment...

Continue reading

Chembio Diagnostics Receives $1.5 Million UNICEF Order for Multiplex Zika Systems

MEDFORD, N.Y., Feb. 12, 2020 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced a $1.5 million purchase order from UNICEF for multiplex Zika tests and Micro Readers following the successful completion of conditions set forth in the previously announced long term arrangement (LTA). This initial order is part of the LTA, which has a total opportunity of up to $3.5 million.Chembio’s multiplex DPP Zika System allows simultaneous and discrete detection of antibodies for both active (IgM) and prior exposure (IgG) to the Zika virus, which is important for both treatment and surveillance.“Our Zika System demonstrated outstanding accuracy while offering rapid detection and ease of use through our point-of-care platform and Micro Reader....

Continue reading

Uxin Announces Appointment of Mr. Zhitian Zhang as Chief Operating Officer

BEIJING, Feb. 12, 2020 (GLOBE NEWSWIRE) — Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), a leading national online used car dealer in China, today announced the appointment of Mr. Zhitian Zhang, who previously served as President of Uxin’s online used car transaction business, to Chief Operating Officer, effective February 11, 2020.Mr. Zhang joined Uxin in April 2012 as General Manager of the Sales Management Center. Mr. Zhang was appointed as President of the online used car transaction business in February 2019 where he was responsible for operations and sales management. Prior to joining Uxin, Mr. Zhang worked for Bitauto Holdings Limited (NYSE: BITA) from 2007 to 2012, first as a Director and then as Vice General Manager of its used car business. Mr. Zhang received his bachelor’s degree in Law from the National Police...

Continue reading

Vaisala’s Board of Directors resolved on a long-term Performance Share Plan

Vaisala CorporationStock exchange releaseFebruary 12, 2020 at 2.30 p.m. (EET)Vaisala’s Board of Directors resolved on a long-term Performance Share PlanVaisala’s Board of Directors approved a Performance Share Plan for company’s key employees. The aim of the long-term plan is to align the objectives of Vaisala’s shareholders and key employees in order to increase the value of the company in the long-term and commit key employees to the company.  The potential rewards from the Performance Share Plan 2020–2022 will be based on the Total Shareholder Return of Vaisala’s share (TSR) and operating profit during the performance period. The rewards to be paid on the basis of the Performance Share Plan 2020–2022, in the event that maximum performance against all the performance criteria is achieved, correspond to the value of an aggregate 240,000...

Continue reading

Vaisala Oyj:n hallitus päätti uudesta pitkän aikavälin suoriteperusteisesta osakepalkkiojärjestelmästä

Vaisala OyjPörssitiedote12.2.2020 klo 14.30Vaisala Oyj:n hallitus päätti uudesta pitkän aikavälin suoriteperusteisesta osakepalkkiojärjestelmästäVaisalan hallitus päätti uudesta avainhenkilöille suunnatusta suoriteperusteista osakepalkkiojärjestelmästä. Pitkän aikavälin järjestelmän tarkoituksena on yhdenmukaistaa Vaisalan osakkeenomistajien ja avainhenkilöiden tavoitteet yhtiön arvon kasvattamiseksi pitkällä aikavälillä sekä sitouttaa avainhenkilöt yhtiöön.Suoriteperusteisen osakepalkkiojärjestelmän 2020–2022 mahdollinen palkkio perustuu Vaisalanosakkeen kokonaistuottoon (TSR) sekä liikevoittoon suorituskauden aikana. Mikäli kaikkien suorituskriteereiden osalta saavutetaan enimmäistaso, suoriteperusteisen osakepalkkiojärjestelmän 2020–2022 perusteella maksettavat palkkiot vastaavat yhteensä 240 000 Vaisalan A-sarjan osaketta, sisältäen...

Continue reading

8i Enterprises Acquisition Corp. Provides Update on Its Intended Merger Target – Diginex

Diginex Appoints Jim Pollock as Its Chief Operating OfficerNEW YORK, Feb. 12, 2020 (GLOBE NEWSWIRE) — 8i Enterprises Acquisition Corp. (NASDAQ: JFK, “JFK” or “8i”) (the “Company”), a special purpose acquisition company, today announced that Diginex, a digital asset financial services and advisory company with which JFK entered into a definitive share exchange agreement dated July 9, 2019, has appointed Jim Pollock as its Chief Operating Officer (COO) based in Singapore.In this role, Mr. Pollock will be responsible for overseeing the implementation of Diginex’s business strategy, which includes the development of fully regulated and institutional grade digital asset infrastructure for the financial services sector.A senior financial services executive with over three decades of experience in multi-jurisdictional business development,...

Continue reading

NexTech Receives New 2020 Contract from Walther Arms Inc., Manufacturer of James Bond’s PPK

NEW YORK and TORONTO, Feb. 12, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), the leader in augmented reality for e-commerce and AR learning applications, has received a new order from Walther Arms, most famous as the manufacturer of James Bond’s Walther PPK. Walther has been a NexTech customer since April 2019 and has had multiple expansion contracts in 2019 with the company. Walther has now signed a new 2020 expansion contract for three more AR experiences.SEE VIDEO OF 3D/AR PRODUCTSCody Osborn, marketing manager at Walther Arms, comments, “NexTech has provided Walther customers a unique experience in shopping for their handgun. We have seen a significant increase in time spent on each webpage that features the Augmented Reality button that NexTech has provided. Our new...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.